bioAffinity Technologies, Inc. (BIAFW)

Market Cap	12.94M
Revenue (ttm)	9.37M
Net Income (ttm)	-8.45M
Shares Out	15.58M
EPS (ttm)	-0.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	186,128
Open	0.520
Previous Close	0.545
Day's Range	0.500 - 0.800
52-Week Range	0.500 - 0.800
Beta	2.97
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About BIAFW

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2014
• Employees: 75
• Stock Exchange: NASDAQ
• Ticker Symbol: BIAFW
• Website: https://www.bioaffinitytech.com

Financial Performance

In 2023, bioAffinity Technologies's revenue was $2.53 million, an increase of 52627.44% compared to the previous year's $4,803. Losses were -$7.94 million, -2.66% less than in 2022.